Letter to the Editor: Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF)
Hepatology
.
2025 Jan 1;81(1):E12-E16.
doi: 10.1097/HEP.0000000000001061.
Epub 2024 Sep 26.
Authors
Mazen Noureddin
1
,
Emily Truong
2
,
Rebeca Mayo
3
,
Ibon Martínez-Arranz
3
,
Itziar Mincholé
3
,
Jesus M Banales
4
5
,
Marco Arrese
6
,
Kenneth Cusi
7
,
María Teresa Arias-Loste
8
,
Radan Bruha
9
,
Manuel Romero-Gómez
10
,
Paula Iruzubieta
8
,
Rocio Aller
11
,
Javier Ampuero
12
,
José Luis Calleja
13
,
Luis Ibañez-Samaniego
14
,
Patricia Aspichueta
15
16
17
,
Antonio Marín-Duce
18
,
Tatyana Kushner
19
,
Pablo Ortiz
3
,
Stephen A Harrison
20
,
Quentin M Anstee
21
,
Javier Crespo
8
,
José M Mato
17
22
,
Arun J Sanyal
23
Affiliations
1
Department of Hepatology, Houston Liver Institute, Houston Research Institute, Houston, Texas, USA.
2
Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.
3
OWL Metabolomics, Derio, Spain.
4
Biodonostia Research Institute, Donostia University Hospital, University of the Basque Country (UPV-EHU), CIBERehd, IKERBASQUE, Donostia, Spain.
5
Department of Biochemistry and Genetics, School of Sciences, University of Navarra, Pamplona, Spain.
6
Department of Gastroenterology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
7
Department of Medicine, University of Florida, Gainesville, Florida, USA.
8
Department of Gastroenterology and Hepatology Marqués de Valdecilla University Hospital, Cantabria University, IDIVAL, Santander, Spain.
9
Fourth Department of Internal Medicine, General University Hospital and the First Faculty of Medicine, Charles University, Prague, Czech Republic.
10
Digestive Diseases Unit and CIBERehd, Valme University Hospital, CIBERehd, Seville, Spain.
11
Clinic University Hospital, University of Valladolid, Valladolid, Spain.
12
UCM Digestive Diseases, Virgen del Rocío University Hospital, Sevilla, Spain.
13
Department of Gastroenterology and Hepatology, Puerta del Hierro University Hospital, Madrid, Spain.
14
Liver Unit, Gregorio Marañón University Hospital, Madrid, Spain.
15
Department of Physiology, Faculty of Medicine and Nursing, University of the Basque Country UPV/EHU, Leioa, Spain.
16
Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.
17
National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, Instituto de Salud Carlos III), Madrid, Spain.
18
Príncipe de Asturias University Hospital, Alcalá University, Madrid, Spain.
19
Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York City, New York, USA.
20
Pinnacle Clinical Research, San Antonio, Texas, USA.
21
Translational & Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
22
CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Derio, Spain.
23
Virginia Commonwealth University Medical Center, Richmond, Virginia, USA.
PMID:
39325967
DOI:
10.1097/HEP.0000000000001061
No abstract available